Heesoo Yoo
Appearances
DateMay 8, 2023BACKGROUND: Sound evidence support the effectiveness of the transoral outlet reduction (TORe) with full-thickness endoscopic suturing (FTS) or argon plasma coagulation (APC) alone to address post-RYGB weight regain…- DateMay 7, 2023INTRODUCTION. Microvascular invasion (MVI) is the main risk factor for overall mortality and recurrence after surgery for hepatocellular carcinoma (HCC). Its diagnosis can be made only postoperatively on the histological specimen…
Presenter
- DateMay 7, 2023BACKGROUND: Despite the advances in the multidisciplinary treatment of gastric adenocarcinoma, the overall 5-year survival remains only 33.3% in North America. R0 resection with adequate lymphadenectomy remains the mainstay therapy…
- DateMay 7, 2023BACKGROUND: Despite the advances in the multidisciplinary treatment of gastric adenocarcinoma, the overall 5-year survival remains only 33.3% in North America. R0 resection with adequate lymphadenectomy remains the mainstay therapy…
- DateMay 7, 2023_Objective_: To investigate the clinical relevance of fecal microbial dysbiosis in HCC development
Presenter
Speakers
DateMay 18, 2024SIMULTANEOUS ROUX-EN-Y GASTRIC BYPASS AND CHOLECYSTECTOMY NATIONWIDE OUTCOMESModerators
Universidade de Sao PauloCleveland Clinic Abu DhabiYale New Haven Health System
